Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

almirall s.a. - lorazepam 1 mg - tablet - 1 mg - lorazepam 1 mg - lorazepam

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

almirall s.a. - lorazepam 2,5 mg - tablet - 2,5 mg - lorazepam 2.5 mg - lorazepam

Singapore - English - HSA (Health Sciences Authority)

ge healthcare pte. ltd. - radiology / imaging - pristina serena is an optional accessory of senographe pristina intended to provide accurate location of lesions in the breast in three dimensions. the pristina serena option provides the three-dimensional location of target lesions, using information obtained from stereotactic pairs of two-dimensional x-ray images. this information provides guidance for a variety of minimally invasive or interventional procedures in the breast such as: vacuum assisted biopsy, core biopsy, pre-surgical localization (e.g. hookwire), and fine needle aspirations (fna).

Malta - English - Medicines Authority

janssen-cilag international nv turnhoutsewes 30, b-2340 beerse, belgium - haloperidol - tablet - haloperidol 5 mg - psycholeptics

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

janssen-cilag ltd - haloperidol - oral solution - 2mg/1ml

Ireland - English - HPRA (Health Products Regulatory Authority)

essential pharma limited - haloperidol - solution for injection - butyrophenone derivatives; haloperidol

Ireland - English - HPRA (Health Products Regulatory Authority)

essential pharma limited - haloperidol - solution for injection - butyrophenone derivatives; haloperidol

Ireland - English - HPRA (Health Products Regulatory Authority)

janssen sciences ireland uc - haloperidol - solution for injection - 100 milligram(s)/millilitre - butyrophenone derivatives; haloperidol

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - haloperidol 5 mg/ml - solution for injection - 5 mg/ml - active: haloperidol 5 mg/ml excipient: lactic acid sodium hydroxide water for injection - the management of manifestations of psychotic disorders such as schizophrenia, psychosis due to organic brain damage or mental deficiency, the manic phase of manic depressive illness, gilles de la tourette syndrome.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - haloperidol, quantity: 5 mg/ml - injection, solution - excipient ingredients: water for injections; sodium hydroxide; (s)-lactic acid - chronic therapy: the management of manifestations of psychotic disorders such as schizophrenia, psychosis due to organic brain damage or mental deficiency, the manic phase of manic depressive illness, gilles de la tourette syndrome. short term therapy: the treatment of acute alcoholism for the relief of delusions, hallucinations and confused states, and for the control of accompanying tremulousness and aggressive behaviour. in the treatment of intractable nausea and vomiting associated with radiation or malignancy and not responding to other therapy. neuroleptanalgesia